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Abstract The purpose of our study was to identify the
influence of tourniquet use during total knee arthroplasty
(TKA) on the neutrophil-to-lymphocyte ratio (NLR)
shortly after surgery and patient-reported outcomes (pain
and physical activity) from outpatient physical therapy.
This retrospective study consisted of 104 subjects who
underwent primary unilateral TKA (51 subjects with and
53 subjects without tourniquet assistance) between 2010
and 2012. The NLR was calculated from the absolute
neutrophil and lymphocyte counts obtained immediately
before and after (1 and 2 days) knee arthroplasty. The Knee
Outcome Survey (KOS) of Activities of Daily Living and
numeric pain scores collected at the first [33.0 (34.2) days
after surgery] and last [85.5 (40.7) days after surgery]
outpatient physical therapy visits were extracted from an
electronic database. The NLR, pain, and KOS score were
not significantly (all p[ 0.05) different with tourniquet
use. Based on these findings, we conclude that tourniquet
use during TKA neither increases systemic inflammation
shortly after surgery nor impairs patient-reported outcomes
obtained during outpatient physical therapy.
Level of evidence IV.
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Introduction
Tourniquet use during total knee arthroplasty (TKA)
improves acuity by creating a bloodless operating field.
However, tourniquet inflation and deflation creates an
ischemia–reperfusion response that increases systemic
inflammation [1]. Inflammation is essential for host defense
and repair processes, but an exaggerated inflammatory
response can be detrimental to a variety of physiological
systems, including musculoskeletal, immune, and cardio-
vascular. In recent years, the neutrophil-to-lymphocyte
ratio (NLR) has emerged as a sensitive index of systemic
inflammation that predicts serious complications, such as
pulmonary embolism or cardiovascular disease risk [2, 3].
Deviations in the NLR are also apparent with contrasting
arthroplasty procedures (unicompartmental versus tricom-
partmental) [4], suggesting that the NLR could serve as an
indicator for systemic inflammation and for the severity of
surgery-induced trauma. Surprisingly, it is unknown if
tourniquet use during TKA alters the NLR.
Tourniquet use also increases pain and physical
impairment in the days after TKA [5], but it is unknown if
tourniquet use impairs outpatient physical rehabilitation in
the months after TKA. The purpose of our study was to
identify the influence of tourniquet use during TKA on the
NLR and patient-reported outcomes from outpatient
physical therapy. We hypothesized that tourniquet-assisted
TKA would exacerbate the increase in the NLR shortly
after surgery and impair patient-reported outcomes (pain
and physical function) during outpatient physical therapy.
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Patients who underwent primary unilateral TKA were ret-
rospectively identified using the International Classification
of Diseases, 9th Revision code and limited to surgeries
performed at one facility (The Orthopedic Specialty
Hospital, Murray, UT USA) by one orthopedic surgeon
between 2010 and 2012 (n = 462). This time frame was
selected because half-way through 2011 the participating
surgeon discontinued tourniquet use during TKA without
altering other standard of care practices. For the purpose of
limiting guideline and practice variability, we also exclu-
ded (n = 358) subjects who performed outpatient physical
therapy at a separate facility. The final analysis consisted of
104 subjects—51 subjects with and 53 subjects without
tourniquet assistance during TKA. Postoperative compli-
cations were documented for each subject. This study was
approved by the Institutional Review Board at Inter-
mountain Healthcare (Salt Lake City, UT USA).
On the day of surgery, the subjects were taken to the
operating room and placed on the table in a supine position
while a femoral nerve block was administered. Following
administration, the subjects were assisted to a sitting
position while spinal anesthetic was provided. The subjects
were returned to a supine position and the involved limb
was prepared and draped, after which prophylactic antibi-
otics were administered. For the tourniquet group, the leg
was exsanguinated with an Esmarch bandage, and the
tourniquet was placed as high as possible on the thigh of
the surgical leg, over cast padding, and inflated to
300 mmHg.
Subjects underwent a tricompartmental knee arthro-
plasty through a medial parapatellar arthrotomy approach
with uncemented fixation. After surgery, the tourniquet was
deflated (when a tourniquet was used), and following
wound closure, a Fresenius Cell Saver (Redmond, WA,
USA) Hemovac drain was put in place in the joint. The
medial parapatellar arthrotomy was initially closed using
sutures followed by staples or sutures to close subcuta-
neous tissues and skin in layers. Adaptic and a sterile
dressing were applied to the wounds. Subjects were then
transferred to the recovery room. In the post-anesthesia
care unit, subjects from both groups received patient-con-
trolled analgesia with hydromorphone through a continu-
ous ambulatory delivery device. The Fresenius Cell Saver
system drains were removed on the first day after surgery.
Tranexamic acid was not used in any subject and no sub-
jects received a reinfusion after TKA.
The NLR was calculated from the absolute neutrophil
and lymphocyte counts obtained immediately before (Pre)
and after (1 and 2 days) TKA. Outpatient physical reha-
bilitation was initiated 33 (34.2) days after surgery. The
Knee Outcome Survey (KOS) of Activities of Daily Living
and numeric pain rating scale (0–10 for current pain) scores
from the first and last physical therapy visits [52.5 (25.8)
days between visits] and number of physical therapy visits
[11.4 (5.9)] were extracted from an electronic database.
Subjects were classified as responders if their KOS score
increased by C11 points [6] or if their pain score decreased
by C2 points [7].
Data were checked for normality prior to all statistical
analyses with the Shapiro–Wilk test. Subject differences
between tourniquet groups were assessed using a two-
sample t test with a Bonferroni adjusted p value. Cate-
gorical variable differences between groups were evaluated
using separate Pearson chi-squared tests. Blood chemistry
and outpatient physical rehabilitation outcome differences
between groups were assessed with separate repeated
measures analysis of variance followed by a Bonferroni
correction on multiple pairwise comparisons when appro-
priate. All statistical analyses were performed with
SYSTAT (version 13.1, Chicago, IL USA). Data are pre-
sented as mean (SD) unless noted otherwise.
Results
Subject characteristics, preoperative blood chemistries,
American Society of Anesthesiologists (ASA) score, sur-
gery time, length of stay, and postoperative complications
were not significantly different between tourniquet groups
(Tables 1 and 2; all p[ 0.05). Tourniquet use during TKA
did not magnify surgery-induced alterations in white blood
cell count (WBC), neutrophil or lymphocyte absolute
counts, the NLR, hemoglobin, or hematocrit levels
(Table 2; all p[ 0.05). Likewise, pain and KOS scores
were not significantly different between groups (p value
range 0.20-0.98).
Discussion
In contrast to our hypothesis, the increase in the NLR was
not modulated by tourniquet use during TKA. This finding
is consistent with a previous study demonstrating that
tourniquet-assisted TKA did not exacerbate the systemic
increase in C-reactive protein following knee arthroplasty
[8]. However, the findings by Matziolis et al. [8] and those
in the present study could be limited by protocol design as
the earliest postoperative assessments of systemic inflam-
mation were performed 1 day after surgery. Consistent with
this perceived limitation, data demonstrate an exaggerated
inflammatory response within 24 h after tourniquet-assisted
TKA [1]. Thus, the systemic inflammatory response to
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tourniquet-assisted TKA could be temporally dependent
with deviations likely apparent within the first 24 h after
surgery.
Similar to the NLR, pain levels reported during outpa-
tient physical therapy were not altered by tourniquet use
during TKA. This finding contrasts with an earlier report
showing tourniquet use during TKA increases postopera-
tive pain shortly (4 h) after knee arthroplasty [9]. Consid-
ering the present study’s first postoperative pain assessment
was obtained *33 days after surgery, it is plausible that
tourniquet-induced pain is more readily apparent within
hours but not days after TKA.
Data also indicate that tourniquet assistance during TKA
impedes progression in an objective-based measure of
physical performance, such as muscle strength and knee
range of motion [9]. However, in the present investigation,
tourniquet use did not alter patient-reported physical
activity levels during outpatient physical therapy. While
improvements in subjective-based outcomes exceed those
of more objectively routed measures following TKA [10],
it remains unknown if tourniquet use during TKA con-
tributes to the discordance of findings between subjective
and objective outcomes after surgery. Clearly, future
research investigating the role of tourniquet use on sub-
jective- and objective-based physical performance out-
comes following TKA is warranted.
There are some limitations with this study that are
worthy of discussion. First, besides the NLR, no other
biomarkers of systemic inflammation were examined.
However, previous research performed in non-orthopedic
patients (i.e., cardiovascular and colorectal cancer)
demonstrates that the NLR associates with other common
indices of systemic inflammation, such as C-reactive pro-
tein and interleukin-6 [11, 12]. Second, including blood
clotting, range of motion, and objective-based outcomes
would strengthen the evaluation of tourniquet use during
knee arthroplasty. Future research is needed to identify the
association between the NLR and other systemic indices of
inflammation and objective-based outcomes following
TKA.
In summary, tourniquet use during TKA did not increase
systemic inflammation or hinder patient-reported out-
comes. Based on these findings, we conclude that tourni-
quet use during TKA neither increases systemic
inflammation nor is detrimental to patient-reported out-
comes during physical therapy.
Table 1 Subject and general
surgery characteristics
T- T? p value
n (f/m) 53 (28/25) 51 (33/18) 0.22
Age, years 62 (10) 63 (13) 0.81
Height, cm 170 (11) 170 (12) 0.99
Body mass, kg 96.2 (24.7) 99.3 (25.8) 0.53
Body mass index, kg/m2 33.2 (7.3) 34.4 (8.0) 0.42




Knee, left/right 23/30 27/24 0.33
Surgery time, min 125 (17) 121 (18) 0.28
Tourniquet, min NA 73.6 (23.5) NA
Length of stay, days 3.04 (0.39) 2.96 (0.28) 0.25
Infections, n 1 0 0.32
Allogeneic transfusions, n 0 2 0.15
Manipulations under anesthesia, n 4 9 0.12
Pulmonary embolisms, n 0 0 NA
Deep venous thromboembolism, n 0 0 NA
Readmissions, n** 4 1 0.18
Data presented as mean (SD) unless noted otherwise. T- non-tourniquet-assisted TKA, T? tourniquet-
assisted TKA, NA not applicable
* ASA score was missing for 1 T- subject and for 3 T? subjects













Pre vs 1 day Pre vs 2 days 1-day vs 2 days
Hemoglobin, g/dL 0.47 \0.001 0.10 \0.001 \0.001 \0.001
Pre 14.0 (1.5) 14.0 (1.6)
1-day post 12.0 (1.5) 12.2 (1.4)
2-day post 11.0 (1.3) 11.3 (1.3)
Hematocrit, % 0.77 \0.001 0.78 \0.001 \0.001 \0.001
Pre 40.9 (5.6) 40.9 (6.5)
1-day post 35.6 (4.3) 35.7 (4.1)
2-day Post 32.7 (3.7) 33.1 (3.8)
WBC, K/uL 0.15 \0.001 0.50 \0.001 \0.001 \0.001
Pre 7.34 (2.42) 6.60 (1.50)
1-day post 11.2 (3.0) 10.3 (2.8)
2-day post 9.63 (2.33) 9.22 (2.00)
Neutrophils, K/uL 0.38 \0.001 0.47 \0.001 \0.001 \0.001
Pre 4.37 (1.34) 4.04 (1.24)
1-day post 8.75 (2.31) 8.21 (2.64)
2-day post 6.78 (1.59) 6.72 (1.65)
Lymphocytes,
K/uL
0.58 \0.001 0.27 \0.001 0.004 0.001
Pre 2.06 (1.26) 1.88 (0.57)
1-day post Post 1.38 (1.42) 1.17 (0.54)
2-day post Post 1.64 (1.23) 1.72 (1.08)
NLR 0.44 \0.001 0.80 \0.001 \0.001 \0.001
Pre 2.40 (0.89) 2.35 (1.06)
1-day post 8.62 (5.00) 8.19 (4.07)
2-day post 5.41 (3.32) 4.82 (2.35)
D1 6.23 (4.96) 5.78 (3.88) 0.61






Pain 0.20 \0.001 0.46
First PT visit 5.22 (2.24) 4.79 (2.23)






Pain responder 26 33 0.24
KOS 0.82 \0.001 0.87
First PT visit 46.7 (17.1) 47.9 (16.9)
Last PT visit 68.6 (18.4) 69.9 (17.0)
KOS D 21.9 (16.3) 21.8 (19.3) 0.98
KOS responder 36 42 0.31
Data presented as mean (SD)
T- non-tourniquet-assisted TKA, T? tourniquet-assisted TKA, PT physical therapy, WBC white blood cell, D1 change from Pre to 1 day, D2
change from Pre to 2 days, D1-2 change from 1 day to 2 day
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